NDT Advance Access originally published online on March 6, 2006
Nephrology Dialysis Transplantation 2006 21(5):1145-1153; doi:10.1093/ndt/gfl084
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author [2006]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Editorial Comment
Clinical Practice Guidelines in nephrologyfor worse or for better
National Kidney Foundation Center for Clinical Practice Guideline Development and Implementation, Tufts-New England Medical Center, Boston, USA
Correspondence and offprint request to: Katrin Uhlig, Email: kuhlig@tufts-nemc.org
Keywords: clinical practice guidelines; systematic review; evidence grading; chronic kidney disease
| The first 150 words of the full text of this article appear below. |
| Introduction |
|---|
Clinical practice guidelines (CPGs)* (throughout the text, terms marked with an asterisk are defined in Table 1 in alphabetical order) [1] have become important tools in shaping the care of individuals with chronic kidney disease (CKD). CPGs inform patient care, scientific debate, research agendas and policies. At the same time, CPGs have been criticized for restricting the care provided by physicians to patients. This article is intended as a review of selected topics related to guideline development and its application in nephrology, which ultimately aim at informing decision making and improving the quality of care.
|
| What guidelines are and are not |
|---|
The primary purpose of CPGs is to improve patient care. As defined in the Institute of Medicine's 1990 report, guidelines are systematically developed statements to assist practitioner and patient decisions about appropriate health care for specific clinical circumstances[1,2]. CPGs are evidence-based when they are derived from
| Methodological challenges for guideline development |
|---|
Evidence grading
Quality of evidence in nephrology
| Guideline development in nephrology |
|---|
Guideline implementation
Challenges in international guideline development
| Conclusions |
|---|
This article has been cited by other articles:
![]() |
E. Will Intention and outcome in guideline-based nephrological practice: a suitable space for 'clinical technology' Nephrol. Dial. Transplant., November 1, 2007; 22(11): 3110 - 3114. [Full Text] [PDF] |
||||
![]() |
I. C. Macdougall, K.-U. Eckardt, and F. Locatelli Latest US KDOQI Anaemia Guidelines update what are the implications for Europe? Nephrol. Dial. Transplant., October 1, 2007; 22(10): 2738 - 2742. [Full Text] [PDF] |
||||
![]() |
D. Van Wyck, K.-U. Eckardt, K. Uhlig, M. Rocco, and A. Levin Appraisal of Evidence and Control of Bias in the Kidney Disease Outcomes Quality Initiative Guideline Development Process Clin. J. Am. Soc. Nephrol., January 1, 2007; 2(1): 8 - 10. [Full Text] [PDF] |
||||

